BioAge Labs Target Price

Where could BIOA trade next? Consensus target price: $31.

Get informed when a big investor buys or sells

+ Follow

Share Price

$10.4

Average Target Price

$30.50

193.3% upside

4 analysts in the last 4 months

High: $40 | Low: $21

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-07-31	Roth CapitalAdam Walsh	$25	140.4% upside
2026-07-31	Jefferies	$21	101.9% upside
2026-05-27	Roth CapitalAdam Walsh	$36	246.2% upside
2026-05-13	BTIG	$40	284.6% upside
2026-03-27	Needham	$50	380.8% upside
2026-02-18	JefferiesRoger Song	$62	496.2% upside
2026-02-04	Morgan Stanley	$23	121.2% upside
2025-12-05	Morgan Stanley	$12	15.4% upside
2025-03-07	Morgan Stanley	$5	51.9% downside
2024-12-09	JefferiesRoger Song	$7	32.7% downside
2024-10-21	CitigroupSamantha Semenkow	$45	332.7% upside
2024-10-21	JefferiesRoger Song	$42	303.8% upside
2024-10-21	Morgan StanleyJeffrey Hung	$40	284.6% upside

BioAge Labs (BIOA) FAQ

BioAge Labs (BIOA) currently reports a target price of $31. Use the charts on this page to explore BioAge Labs's target price history and peer comparisons.

Analysts' average 12-month price target for BioAge Labs is $31, about 193.3% upside from the current share price of $10.4. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $31, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for BioAge Labs, and consider following BIOA for alerts when major investors trade the stock.